Validation of a harmonized Spanish version of the IPSS: Evidence of equivalence with the original American scale

Urology

Volumn 52, Issue 4, 1998, Pages 614-620

  Badía, Xavier ^a   García Losa, Manuel ^b   Dal Ré, Raeael ^b   Carballido, Joaquín ^b   Serra, Mateu ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SCORING SYSTEM; SPAIN;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SPAIN; UNITED STATES;

EID: 0032188890     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00204-0     Document Type: Article

References (22)

1. Barry MJ, Fowler FJ Jr, O'Leary MP, et al: The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 148: 1549-1557, 1992.
2. Barry MJ, Coffey DC, Fitzpatrick J, et al: Recommendations of the International Consensus Committee concerning patient evaluation for research studies, in Cockett ATK, Aso Y, Chatelain C, et al (Eds): Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH), 1991, Paris. Channel Islands, Scientific Communication International, 1991, pp 279-281.
3. Cella DF, Wiklund 1, Shumaker SA, et al: Integrating health-related quality ol life into cross-national clinical trials. Qual Life Res 2: 433-440, 1993.
4. Badia X, García-Losa M, and Dal-Ré R: Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Fur Urol 31: 129-140, 1997.
5. Badia X, Fernández E, and Segura A: Influence of sociodemographic and health status variables on evaluation of health states in a Spanish population. Fur J Public Health 5: 87-93, 1995.
6. Badia X: Validity and reproducibility of the Psychological General Well-Being Index. Quality Life Res 5: 101-105, 1996.
7. McConnell JD, Barry MJ, Bruskewitz RC, et al: Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline, Number 8. AHCPR Publication No. 94-0582. Rockville, Maryland, Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, February 1994.
8. Dupuy HJ: Sell-representations of general psychological well-being of American adults. American Public Health Association Meeting, Los Angeles, California, October 17, 1978.
9. Epstein RS, Deverka PA, Chute CG, et al: Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 45: 1431-1445, 1992.
10. Brooks R, with the EuroQol Group: EuroQol: the current state of play. Health Policy 37: 53-72, 1996.
11. Macdonagh R, Cliff AM, Speakman MJ, et al: The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol 79: 401-408, 1997.
12. Hanley JA, and McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36, 1982.
13. Deyo RA, Diehr P, and Patrick DL: Reproducibility and responsiveness of health status measures. Control Clin Trials 12(suppl): 142S-158S, 1991.
14. Cohen J: Statistical Power Analysis for the Behavioural Sciences. New York, Academic Press, 1977, pp 75-105.
15. Guyatt GH, Walter S, and Norman G: Measuring changes over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40: 171-178, 1987.
16. Hines JEW: Symptom indices in bladder outlet obstruction. Br J Urol 77: 494-501, 1996.
17. Lepor H, and Machi G: Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 42: 36-41, 1993.
18. Chai TC, Belville WD, McGuire EJ, et al: Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes. J Urol 150: 1710-1713, 1993.
19. Badia X, García-Losa M, Serra M, et al: Symptom indexes and quality of life questionnaires in clinical research for benign prostatic hyperplasia. Dis Manage Health Outcomes 2: 291-301, 1997.
20. Vela Navarrete R, Martin JM, Calahorra FJ, et al: Validación cultural y lingüística, en castellano, del baremo internacional de sintomas prostícos (I-PSS). Actas Urol Sp 18: 841-847, 1994.
21. Batista-Miranda JE, Regalado-Pareja R, Chechile G, et al: Cuestionario IPSS en pacientes y controles. Validación psicométrica. Actas Urol Sp 19: 93-101, 1995.
22. Sagnier PP, Richard F, Botto H, et al: Adaptation and cultural validation in French language of the International Prostate Symptom Score (I-PSS) and quality of life assessment, in Cockett ATK, Khoury S, Aso Y, et al (Eds): Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), June 27-30, 1993, Paris. Paris, Scientific Communication International, 1994, pp 144-147.